Reliq Health Technologies, Inc. Announces 8 New Contracts to Onboard Patients in CA, MI, NV and TX, Adds MiUGO Patient Portal to iUGO Care RTM
May 11 2022 - 03:01AM
Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or
WKN:A2AJTB) (“
Reliq” or the
“
Company”), a rapidly growing global healthcare
technology company that develops innovative Virtual Care solutions
for the multi-billion dollar Healthcare market, today announced
that it has signed new contracts with six physician practices and
two home health agencies that are expected to onboard over 5,000
new patients from California, Michigan, Nevada and Texas to the
Reliq platform in 2022. The Company also announced that it has
incorporated the MiUGO patient portal in its Remote Therapeutic
Monitoring (RTM) module to facilitate symptom reporting for
musculoskeletal and respiratory patients.
“Under the new Remote Therapeutic Monitoring
(RTM) billing codes introduced this year, physicians can now
collect qualitative data from musculoskeletal and respiratory
patients,” said Dr. Lisa Crossley, CEO at Reliq Health
Technologies, Inc. “Using the MiUGO patient portal, patients with
arthritis, asthma and other eligible musculoskeletal and
respiratory conditions can complete daily surveys to document pain
levels, fatigue, mobility issues, wheezing, interrupted sleep due
to pain or shortness of breath, and other key health metrics. This
allows patients and clinicians to determine the impact of
prescribed therapies on the patient’s ability to perform typical
activities of daily life. Self assessment surveys are a critically
important tool for measuring and monitoring the progression of
musculoskeletal and respiratory disease. The iUGO Care RTM module
also uses specialized connected devices to monitor medication
adherence and provide automated medication reminders. Medication
compliance correlates strongly with reduced hospital admissions,
improved health outcomes and better patient-reported quality of
life.”
The Company has signed 8 new contracts with six
physician practices and two home health agencies that are expected
to onboard over 5,000 new patients in California, Michigan, Nevada
and Texas to the Reliq platform in 2022. Onboarding will begin next
month and is expected to be completed by the end of the calendar
year. The contracts are expected to generate an average revenue of
over $60 per patient per month at 75% gross margin.
Reliq Health Reliq Health
Technologies is a rapidly growing global healthcare technology
company that specializes in developing innovative Virtual Care
solutions for the multi-billion dollar Healthcare market. Reliq’s
powerful iUGO Care platform supports care coordination and
community-based virtual healthcare. iUGO Care allows complex
patients to receive high quality care at home, improving health
outcomes, enhancing quality of life for patients and families and
reducing the cost of care delivery. iUGO Care provides real-time
access to remote patient monitoring data, allowing for timely
interventions by the care team to prevent costly hospital
readmissions and ER visits. Reliq Health Technologies trades on the
TSX Venture under the symbol RHT, on the OTC as RQHTF and on the
Frankfurt Stock Exchange under the WKN: A2AJTB.
ON BEHALF OF THE BOARD“Dr. Lisa Crossley”CEO and Director
For further information please contact:
Company ContactInvestor Relations at
ir@reliqhealth.com
US Investor Relations ContactInvestor
RelationsLytham Partners, LLCBen ShamsianNew York |
Phoenix646-829-9701shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward
Looking Information
Certain statements in this press release
constitute forward-looking statements, within the meaning of
applicable securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking
statements" involve known and unknown risks and uncertainties that
could cause actual and future events to differ materially from
those anticipated in such statements.
Forward-looking statements include, but are not
limited to, statements with respect to commercial operations,
including technology development, anticipated revenues, projected
size of market, and other information that is based on forecasts of
future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the
"Company") does not intend and does not assume any
obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology
development and marketing activities, the Company's historical
experience with technology development, uninsured risks. Actual
results may differ materially from those expressed or implied by
such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Mar 2023 to Mar 2024